Friday – Basic Science Track B

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2026.

Please evaluate the speakers

Topic and Speaker(s)
ExcellentGoodFairPoor
The degradation of botulinum neurotoxin light chains using PROTACs
Patrick McNutt, PhD (USA)
Development of an European Equine Tetravalent Botulism Antitoxin and Novel Purified F(ab’)2 Botulinum Type A, B, E and F Antitoxin Reference Materials
Jasmin Weisemann, PhD (Germany)
Neuronal membrane-derived nanodiscs for broad-spectrum neurotoxin detoxification
Liangfang Zhang, PhD (USA)
Intraneuronal delivery of VHHs to reverse BoNT intoxication
Shin-Ichiro Miyashita, PhD (Japan)
A High-Throughput Human Neuromuscular Junction-on-a-Chip Platform to Advance Therapeutic Botulinum Toxin Applications and Countermeasures Development
Margaret Magdesian, DO, PhD (Canada)
A Stable and Effective Vaccine Platform for Multivalent Protection Against Botulinum Neurotoxins A, B, and E
Jiafu Wang, PhD (Ireland)
YesNo
The degradation of botulinum neurotoxin light chains using PROTACs
Patrick McNutt, PhD (USA)
Development of an European Equine Tetravalent Botulism Antitoxin and Novel Purified F(ab’)2 Botulinum Type A, B, E and F Antitoxin Reference Materials
Jasmin Weisemann, PhD (Germany)
Neuronal membrane-derived nanodiscs for broad-spectrum neurotoxin detoxification
Liangfang Zhang, PhD (USA)
Intraneuronal delivery of VHHs to reverse BoNT intoxication
Shin-Ichiro Miyashita, PhD (Japan)
A High-Throughput Human Neuromuscular Junction-on-a-Chip Platform to Advance Therapeutic Botulinum Toxin Applications and Countermeasures Development
Margaret Magdesian, DO, PhD (Canada)
A Stable and Effective Vaccine Platform for Multivalent Protection Against Botulinum Neurotoxins A, B, and E
Jiafu Wang, PhD (Ireland)
YesNo
The degradation of botulinum neurotoxin light chains using PROTACs
Patrick McNutt, PhD (USA)
Development of an European Equine Tetravalent Botulism Antitoxin and Novel Purified F(ab’)2 Botulinum Type A, B, E and F Antitoxin Reference Materials
Jasmin Weisemann, PhD (Germany)
Neuronal membrane-derived nanodiscs for broad-spectrum neurotoxin detoxification
Liangfang Zhang, PhD (USA)
Intraneuronal delivery of VHHs to reverse BoNT intoxication
Shin-Ichiro Miyashita, PhD (Japan)
A High-Throughput Human Neuromuscular Junction-on-a-Chip Platform to Advance Therapeutic Botulinum Toxin Applications and Countermeasures Development
Margaret Magdesian, DO, PhD (Canada)
A Stable and Effective Vaccine Platform for Multivalent Protection Against Botulinum Neurotoxins A, B, and E
Jiafu Wang, PhD (Ireland)
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

Scam Warning

Due to scam emails being sent, please note that INA will NOT email you to wire money to anyone on the Board of Directors or anyone else from the INA.

Join Our Mailing List

Click here to sign up, and then manage your subscription.